Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Mesothelioma, Malignant

Esophageal Neoplasms, Lung Neoplasms

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

Brain Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms, Carcinoma, Small Cell

Small Cell Lung Carcinoma

Cancer Pain, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Cough, Lung Neoplasms, Sarcoidosis, Tuberculosis, Lung Diseases, Interstitial

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Pleural Effusion, Pneumothorax, Pleural Effusion, Malignant

Clinical Trials

A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy

APEX

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

Real World Study of MPM in China

Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC

Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC

3D Printing for Nodule Localization

PICARES

TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC

Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

A Hospital Based Survey on Lung Cancer Related-pain in Northern China

High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC

A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis